Silvia Noiman, PhD, MBA: Executive Chairperson. Dr. Noiman is a leading entrepreneur and executive with over 20 years of experience in the Biopharmaceuticals Industry. She is a Venture Partner at Pontifax, founder of many of the Pontifax’s portfolio companies, including, cCAM Biotherapeutics Ltd. where she held an Executive Chairperson position and Eloxx Pharmaceuticals, where she has a CEO position. Previously she was Founder and Senior Vice President of Predix Pharmaceuticals bringing a small early stage drug discovery company from inception to about $500M publicly traded multi-product company progressing four discovery programs to late stage clinical trials and significant big pharma partnerships. Noiman has a PhD in Molecular Biology from Tel Aviv University and Post Doc from the Weizmann Institute of Science. Published numerous papers and co-inventor in several patents.